Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats

Table 3 Effect on rat intestinal bacterial balance of oxazolone-induced experimental colitis (n = 6, log10ⁿ CFU/g)

Group	Colibacter	Bifidobacterium	Acidobacterium	Fusobacterium	Clostridium
NC	6.87±0.4	9.42 ± 0.25	9.61 ± 0.12	2.92 ± 0.42	5.10 ± 0.19
PC	7.54 ± 0.13d	8.88 ± 0.17d	9.01 ± 0.15d	4.37 ± 0.09d	5.69 ± 0.11d
PB	6.56 ± 0.35b	9.62 ± 0.24b	9.92 ± 0.05b	3.57 ± 0.23b	4.85 ± 0.17b
MA	7.16 ± 0.20af	9.54 ± 0.16b	9.48 ± 0.13bf	3.79 ± 0.02b	4.39 ± 0.29b
SB	6.72 ± 0.18be	9.46 ± 0.59b	9.51 ± 0.09bf	3.72 ± 0.02b	4.79 ± 0.18be

^aP < 0.05,

^bP < 0.01 vs PC;

^dP < 0.01 vs NC;

^eP < 0.05,

^fP < 0.01 vs PB. NC: Negative control; PC: Positive control; PB: Probiotic (C. butyricum); MA: Mesalamine; SB: Sodium butyrate.